oasis 1 trial semaglutide First oral made a strong impression in OASIS-1 #obesity with 15% #weightloss now orforglipron leads the impressive pack of new small molecule oral GLP-1RA with robust #Weightloss and good tolerability ADA2023 Who Wins (and Loses) in
Description
Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: A randomized clinical trial
[PMC free article: PMC5702104] [PubMed: 29178944] 4c
Some premium plans will cover weight-loss medications in full, while bare-bones plans will flatly refuse them
Clinical evidence of antidepressant effects of insulin and anti-hyperglycemic agents and implications for the pathophysiology of depression-a literature review
